Anderson Mendes

Dr. Anderson Mendes

orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2020 in Carbohydrate Polymers
Verified
Journal Article
Closed access
ASAurileide M.B.F. Soares
Aurileide M.B.F. Soares
LGLizia M.O. Gonçalves
Lizia M.O. Gonçalves
RFRuanna D.S. Ferreira
Ruanna D.S. Ferreira
JSJefferson M. de Souza
Jefferson M. de Souza
Raul FangueiroRaul Fangueiro
Raul Fangueiro
WCWelter Cantanhede
Welter Cantanhede

1 February 2005 in Biochemical Pharmacology
Verified
Journal Article
Closed access
RCRobson Coutinho-Silva
Robson Coutinho-Silva
DODavid Ojcius
David Ojcius
DGDarek C. Górecki
Darek C. Górecki
PPPedro M. Persechini
Pedro M. Persechini
RBRodrigo da Cunha Bisaggio
Rodrigo da Cunha Bisaggio
PDPhilip M. Dunn
Philip M. Dunn

1 October 2020 in Scientific Reports
Verified
Journal Article
Open access
PDF file
FAFrancisco das Chagas Pereira de Andrade
Francisco das Chagas Pereira de Andrade
AMAnderson Mendes
Anderson Mendes
Chronic inflammation is triggered by numerous diseases such as osteoarthritis, Crohn's disease and cancer. The control of the pro-inflammatory process can prevent, mitigate and/or inhibit the evolution of these diseases. Therefore, anti-inflammatory drugs have been studied as possible compounds to act in these diseases. This paper proposes a computational analysis of eugenol in relation to aspirin and diclofenac and analyzing the ADMET profile and interactions with COX-2 and 5-LOX enzymes, important enzymes in the signaling pathway of pro-inflammatory processes. Through the analysis of ADMET in silico, it was found that the pharmacokinetic results of eugenol are similar to NSAIDs, such as diclofenac and aspirin. Bioinformatics analysis using coupling tests showed that eugenol can bind to COX-2 and 5-LOX. These results corroborate with different findings in the literature that demonstrate anti-inflammatory activity with less gastric irritation, bleeding and ulcerogenic side effects of eugenol. The results of bioinformatics reinforce studies that try to propose eugenol as an anti-inflammatory compound that can act in the COX-2/5-LOX pathways, replacing some NSAIDs in different diseases.

1 November 2020 in Environmental Toxicology and Pharmacology
Verified
Journal Article
Closed access
ANAdriana Maria Viana Nunes
Adriana Maria Viana Nunes
FAFrancisco das Chagas Pereira de Andrade
Francisco das Chagas Pereira de Andrade
LFLívia Alves Filgueiras
Lívia Alves Filgueiras
OMOctávio Augusto de Carvalho Maia
Octávio Augusto de Carvalho Maia
RCRodrigo L.O.R. Cunha
Rodrigo L.O.R. Cunha
AMAnderson Mendes
Anderson Mendes

1 October 2019 in Carbohydrate Polymers
Verified
Journal Article
Closed access
LPLeudimar Aires Pereira
Leudimar Aires Pereira
LRLuizângela da Silva Reis
Luizângela da Silva Reis
FBFelipe Alves Batista
Felipe Alves Batista
AMAnderson Mendes
Anderson Mendes
Josy OsajimaJosy Osajima
Josy Osajima
Edson Silva FilhoEdson Silva Filho
Edson Silva Filho

8 September 2021 in Anti-Cancer Agents in Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
HNHelber A. Negreiros
Helber A. Negreiros
KMKariely Gonçalves de Moura
Kariely Gonçalves de Moura
MNMaria L.L. Barreto Do Nascimento
Maria L.L. Barreto Do Nascimento
DRDébora Caroline Do Nascimento Rodrigues
Débora Caroline Do Nascimento Rodrigues
PFPaulo Michel Pinheiro Ferreira
Paulo Michel Pinheiro Ferreira
JSJoão Marcelo de Castro e Sousa
João Marcelo de Castro e Sousa
Background: Alpha-terpineol is monoterpene alcohol with anti-tumor activity against different tumor cell lines (lung, breast, leukemias and colorectal) through blockage of NF-kB expression, which play an important role in tumor cells growth. Objective: Evaluate the antitumor activity of alpha-terpineol in murine Sarcoma 180 cell line Methods:: For the tests, different cytotoxic and genotoxic assays were used, including Trypan blue, cytokinesis- blocked micronucleus assay, comet assay, agarose gel DNA fragmentation, flow cytometry and cell viability using fluorescence. Ascitic fluid cells from sarcoma 180 were obtained from Mus musculus peritoneal cavity and Alpha-terpineol was tested at 100, 250 and 500 μg/mL. Doxorubicin and Cisplatin were used as positive controls. Results: Cytotoxic effects of alpha-terpineol were found in all concentrations tested, reducing cell viability in 50.9; 38.53; 30.82% at 100, 250 and 500 μg/mL, respectively. Alpha-terpineol induced genotoxic effects due to DNA fragmentation (increased frequency and index of damage), and was clastogenic by increased micronuclei formation, nucleoplasmic bridges and nuclear buds. DNA fragmentation and increased cell death indicated that alpha-terpineol can cause early, late, and necrotic apoptosis. Conclusion: Our data indicate that alpha-terpineol has antitumor activity revealed by cytogenetic mechanisms and / or loss of cell membrane integrity.